Opportunities and Challenges for Long-Acting MPTs
This is a live webinar featuring Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to technical requirements for long-acting MPTs.
May 2018
Click for full info +Opportunities and Challenges for Long-Acting MPTs
![]() | 02 May 2018 This is a live webinar featuring Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to technical requirements for long-acting MPTs. • View Webinar Recording Flexner, C. & Chatterjee, A. |
Full Info:
Resource Type:
Citation:
This live webinar features Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to technical requirements for long-acting MPTs.
Authors: Flexner, C. & Chatterjee, A.
Health Risks(s):
- HIV
- Unintended Pregnancy
Product type(s):
- HIVtreatment
- MPTs
Topic(s):
- Development